HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrike Naumann Selected Research

Brain Injuries (Brain Injury)

6/2020A Single Injection of N-Oleoyldopamine, an Endogenous Agonist for Transient Receptor Potential Vanilloid-1, Induced Brain Hypothermia, but No Neuroprotective Effects in Experimentally Induced Cerebral Ischemia in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrike Naumann Research Topics

Disease

30Neoplasms (Cancer)
10/2021 - 01/2003
26Glioma (Gliomas)
10/2021 - 01/2002
14Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2002
3Brain Neoplasms (Brain Tumor)
10/2019 - 09/2013
2Melanoma (Melanoma, Malignant)
02/2021 - 03/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2021
1Multiple Sclerosis
01/2021
1Vesicular Stomatitis
01/2021
1Atrophy
01/2021
1Sarcopenia
01/2021
1Measles
01/2021
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021
1Vaccinia
01/2021
1Inflammation (Inflammations)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
10/2020
1Brain Injuries (Brain Injury)
06/2020
1Hyperthermia
06/2020
1Hypothermia
06/2020
1Brain Ischemia (Cerebral Ischemia)
06/2020
1Leukemia
03/2020
1Multiple Myeloma
03/2020
1Hypersensitivity (Allergy)
10/2019
1Erectile Dysfunction
03/2016
1Disease Progression
09/2013
1Hypoxia (Hypoxemia)
07/2012
1Anorexia Nervosa
05/2012

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2002
6CytokinesIBA
10/2021 - 01/2006
6LigandsIBA
03/2016 - 01/2003
6Transforming Growth Factor beta (TGF-beta)IBA
01/2015 - 11/2004
5Transcription Factors (Transcription Factor)IBA
10/2021 - 12/2009
4viscum album peptide (Iscador)IBA
01/2019 - 01/2012
3RNA (Ribonucleic Acid)IBA
03/2021 - 01/2021
3Pharmaceutical PreparationsIBA
06/2020 - 10/2019
3Viscum ribosome inactivating proteinIBA
01/2019 - 02/2017
3Carboxypeptidase H (Carboxypeptidase E)IBA
09/2017 - 07/2012
3Matrix Metalloproteinases (MMPs)IBA
08/2017 - 02/2011
3NF-kappa B (NF-kB)IBA
11/2015 - 03/2010
2EnzymesIBA
02/2021 - 07/2012
2Therapeutic UsesIBA
10/2019 - 02/2011
2Glucose (Dextrose)FDA LinkGeneric
09/2017 - 07/2012
2LectinsIBA
02/2017 - 01/2012
2InterleukinsIBA
11/2015 - 01/2004
2Histone Deacetylase InhibitorsIBA
08/2013 - 04/2013
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2011 - 03/2010
2Messenger RNA (mRNA)IBA
02/2011 - 08/2005
2Phosphotransferases (Kinase)IBA
02/2011 - 01/2006
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
10/2008 - 01/2006
2micaIBA
02/2006 - 12/2003
2DecorinIBA
01/2006 - 11/2004
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2021
1AsparagineIBA
02/2021
1ProteomeIBA
02/2021
1Asparaginase (Elspar)FDA Link
02/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1pleiotrophin (HARP)IBA
01/2021
1Neuroprotective AgentsIBA
06/2020
1N-oleoyldopamineIBA
06/2020
13- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA
06/2020
1Histones (Histone)IBA
03/2020
1MethyltransferasesIBA
03/2020
1Lysine (L-Lysine)FDA Link
03/2020
1CateninsIBA
10/2019
1Deoxyribonuclease I (Nickase)IBA
10/2019
1ChromatinIBA
10/2019
1Phenobarbital (Luminal)FDA Link
10/2019
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
10/2019
1XenobioticsIBA
10/2019
1Temozolomide (Temodar)FDA LinkGeneric
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
09/2017
1Lactic Acid (Lactate)FDA LinkGeneric
09/2017
1Sildenafil Citrate (Viagra)FDA Link
03/2016
1C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA
03/2016
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
03/2016
1Cyclic GMP-Dependent Protein Kinase Type IIBA
03/2016
1atrial natriuretic factor receptor BIBA
03/2016
1Chemokine CXCL1IBA
11/2015
1Interleukin-8 (Interleukin 8)IBA
11/2015
1MitogensIBA
01/2015
1hypericinIBA
12/2013
1Biomarkers (Surrogate Marker)IBA
09/2013
1theasinensin AIBA
04/2013
1trichostatin A (A 300)IBA
04/2013
1antiglomerular basement membrane antibodyIBA
04/2013
1NeuropeptidesIBA
07/2012
1Oxygen (Dioxygen)IBA
07/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011
1Carrier Proteins (Binding Protein)IBA
02/2011
1mithramycin AIBA
02/2011

Therapy/Procedure

19Therapeutics
03/2021 - 01/2003
4Drug Therapy (Chemotherapy)
01/2019 - 09/2003
4Immunotherapy
04/2013 - 12/2003
3Radiotherapy
01/2006 - 01/2002
2Investigational Therapies (Experimental Therapy)
10/2008 - 02/2006
1Denervation
01/2021
1Lasers (Laser)
01/2021
1Intranasal Administration
10/2020
1Transplantation
10/2020
1Induced Hypothermia
06/2020